Clinical pharmacokinetics and therapeutic efficacy of esmolol

Clinical Pharmacokinetics

Volumn 51, Issue 6, 2012, Pages 347-356

  Wiest, Donald B ^a   Haney, Jason S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Beta 1 adrenergic receptor antagonists.; Esmolol; Pharmacokinetics; Pharmacology

Indexed keywords

CATECHOLAMINE; DILTIAZEM; ESMOLOL; LABETALOL; NICARDIPINE;

ACUTE HEART INFARCTION; BRAIN BLOOD FLOW; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CATATONIA; CATECHOLAMINE BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MONITORING; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; ENDOTRACHEAL INTUBATION; EXTUBATION; GRAND MAL SEIZURE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART SURGERY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; LARYNGOSCOPY; MAJOR AFFECTIVE DISORDER; MANIA; OFF PUMP SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; SCHIZOPHRENIA; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; CARDIOVASCULAR DISEASES; HUMANS; PERIOPERATIVE CARE; PROPANOLAMINES;

EID: 84860490448     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/11631590-000000000-00000     Document Type: Review

References (59)

1. Wiest D. Esmolol: a review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet 1995 Mar; 28 (3): 190-202
2. Wiest DB, Garner SS, Uber WE, et al. Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 1998 Apr; 115 (4): 890-7 (Pubitemid 28196601)
3. Gray RJ, Bateman TM, Czer LS, et al. Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension. Am J Cardiol 1987 Apr 1; 59 (8): 887-91 (Pubitemid 17061308)
4. Tabbutt S, Nicolson SC, Adamson PC, et al. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg 2008 Aug; 136 (2): 321-8
5. Adamson PC, Rhodes LA, Saul JP, et al. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol 2006 Jul-Aug; 27 (4): 420-7 (Pubitemid 44222393)
6. de Bruijn NP, Reves JG, Croughwell N, et al. Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy. Anesthesiology 1987 Mar; 66 (3): 323-6 (Pubitemid 17095256)
7. Jacobs JR, Croughwell ND, Goodman DK, et al. Effect of hypothermia and sampling site on blood esmolol concentrations. J Clin Pharmacol 1993 Apr; 33 (4): 360-5 (Pubitemid 23141534)
8. Brevibloc. Premixed injection (esmolol hydrochloride) [package insert]. Deerfield (IL): Baxter Healthcare Corporation [online]. Available from URL: http://www.brevibloc.com/downloads/brevibloc-pi.pdf?mnu1 [Accessed 2012 Mar 19]
9. Edwards ND, Alford AM, Dobson PM, et al. Myocardial ischaemia during tracheal intubation and extubation. Br J Anaesth 1994 Oct; 73 (4): 537-9 (Pubitemid 24307349)
10. Hartley M, Vaughan RS. Problems associated with tracheal extubation. Br J Anaesth 1993 Oct; 71 (4): 561-8 (Pubitemid 23293944)
11. Yu SK, Tait G, Karkouti K, et al. The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg 2011 Feb; 112 (2): 267-81
12. Figueredo E, Garcia-Fuentes EM. Assessment of the efficacy of esmolol on the haemodynamic changes induced by laryngoscopy and tracheal intubation: a meta-analysis. Acta Anaesthesiol Scand 2001 Sep; 45 (8): 1011-22 (Pubitemid 32912349)
13. Feng CK, Chan KH, Liu KN, et al. A comparison of lidocaine, fentanyl, and esmolol for attenuation of cardiovascular response to laryngoscopy and tracheal intubation. Acta Anaesthesiol Sinica 1996 Jun; 34 (2): 61-7
14. Atlee JL, Dhamee MS, Olund TL, et al. The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation. Anesth Analg 2000 Feb; 90 (2): 280-5 (Pubitemid 30078001)
15. Kovac AL, Masiongale A. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation. J Cardiothorac Vasc Anesth 2007 Feb; 21 (1): 45-50 (Pubitemid 46199246)
16. Garnock-Jones KP. Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension. Drugs 2012 Jan 1; 72 (1): 109-32
17. Fallouh HB, Kentish JC, Chambers DJ. Targeting for cardioplegia: arresting agents and their safety. Curr Opin Pharmacol 2009 Apr; 9 (2): 220-6
18. Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 2003 Feb; 75 (2): S661-6 (Pubitemid 36187447)
19. Pirk J, Kellovsky P. An alternative to cardioplegia. Ann Thorac Surg 1995 Aug; 60 (2): 464-5
20. Fallouh HB, Bardswell SC, McLatchie LM, et al. Esmolol cardioplegia: the cellularmechanismof diastolic arrest.CardiovascRes 2010Aug 1; 87 (3): 552-60
21. Kuhn-Regnier F, Natour E, Dhein S, et al. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Eur J Cardiothorac Surg 1999 Jan; 15 (1): 67-74 (Pubitemid 29084554)
22. Geissler HJ, Davis KL, Laine GA, et al. Myocardial protection with high-dose beta-blockade in acute myocardial ischemia. Eur J Cardiothorac Surg 2000 Jan; 17 (1): 63-70 (Pubitemid 30109384)
23. Mehlhorn U, Sauer H, Kuhn-Regnier F, et al. Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovascular surgery 1999 Aug; 7 (5): 549-57 (Pubitemid 29349672)
24. Kuhn-Regnier F, Geissler HJ, Marohl S, et al. Beta-blockade in 200 coronary bypass grafting procedures. Thorac Cardiovasc Surg 2002 Jun; 50 (3): 164-7 (Pubitemid 34760512)
25. Scorsin M, Mebazaa A, Al Attar N, et al. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia. J Thorac Cardiovasc Surg 2003 May; 125 (5): 1022-9 (Pubitemid 36644878)
26. Hekmat K, Clemens RM, Mehlhorn U, et al. Emergency coronary artery surgery after failed PTCA: myocardial protection with continuous coronary perfusion of beta-blocker-enriched blood. Thorac Cardiovasc Surg 1998 Dec; 46 (6): 333-8 (Pubitemid 29035861)
27. Abramson DC, Pivalizza EG, Gottschalk LI. Drug management for coronary revascularization without cardiac standstill: the use of high-dose esmolol. J Cardiothorac Vasc Anesth 1995 Apr; 9 (2): 184-8
28. Matsuda H, Fukushima N, Kadoba K, et al. Application of ultra short acting beta blockade (esmolol) in pediatric open heart surgery: a trial in total anomalous pulmonary venous return. J Card Surg 1996 Nov-Dec; 11 (6): 411-5; discussion 6 (Pubitemid 127496588)
29. Borowski A, RajiMR, Eichstaedt HC, et al.Myocardial protection by pressureand volume-controlled continuous hypothermic coronary perfusion in combination with esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients. Eur J Cardiothorac Surg 1998 Sep; 14 (3): 243-9 (Pubitemid 28417076)
30. Peterzen B, Lonn U, Babi'c A, et al. Anesthetic management of patients undergoing coronary artery bypass grafting with the use of an axial flow pump and a short-acting beta-blocker. J Cardiothorac Vasc Anesth 1999 Aug; 13 (4): 431-6 (Pubitemid 29383900)
31. Ti LK, Cheong KF, Chen FG. Esmolol resistance during anesthesia for thoracoscopically assisted coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1998 Jun; 12 (3): 317-20
32. Aleksic I, Buhre W, Baryalei MM, et al. Haemodynamic changes during minimally invasive coronary artery bypass surgery using high-dose esmolol. Cardiovasc Surg 2000 Apr; 8 (3): 204-7 (Pubitemid 30224661)
33. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004 Oct 5; 110 (14): e340-437
34. Geissler HJ, Davis KL, Buja LM, et al. Esmolol and cardiopulmonary bypass during reperfusion reduce myocardial infarct size in dogs. Ann Thorac Surg 2001 Dec; 72 (6): 1964-9 (Pubitemid 34001450)
35. Barham NJ, Boomers OW, Sherry KM, et al. Myocardial ischaemia during tracheal extubation in patients after cardiac surgery: an observational study. Br J Anaesth 1998 Jun; 80 (6): 832-3 (Pubitemid 28282560)
36. Kurian SM, Evans R, Fernandes NO, et al. The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia 2001 Dec; 56 (12): 1163-8 (Pubitemid 33103867)
37. Tempe DK, Mulchandani P, Tandon MS, et al. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol. IndianHeart J 1999May-Jun; 51 (3): 294-300 (Pubitemid 29383776)
38. Zangrillo A, Turi S, Crescenzi G, et al. Esmolol reduces perioperative ischemia in cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009 Oct; 23 (5): 625-32
39. St Andre AC, DelRossi A. Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med 2005 Sep; 33 (9): 2082-93 (Pubitemid 41306534)
40. Harwood TN, Butterworth J, Prielipp RC, et al. The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth 1999 Oct; 13 (5): 555-61 (Pubitemid 29482695)
41. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999 Mar; 88 (3): 477-82 (Pubitemid 29109006)
42. Urban MK, Markowitz SM, Gordon MA, et al. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000 Jun; 90 (6): 1257-61 (Pubitemid 30351320)
43. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008 May 31; 371 (9627): 1839-47
44. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009 Jun; 249 (6): 921-6
45. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2009 Nov 24; 120 (21): e169-276
46. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med 2005 Jun 16; 352 (24): 2524-33 (Pubitemid 41007868)
47. Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA Focused Update Incorporated Into theACC/AHA2007Guidelines for theManagement of PatientsWith Unstable Angina/Non-ST-ElevationMyocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011 May 10; 123 (18): e426-579
48. Barth C, Ojile M, Pearson AC, et al. Ultra short-acting intravenous betaadrenergic blockade as add-on therapy in acute unstable angina. Am Heart J 1991 Mar; 121 (3 Pt 1): 782-8
49. Guarracino F, Landoni G, Baldassarri R, et al. Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock. Br J Anaesth 2010 Mar; 104 (3): 388-9
50. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation 2008 Dec 9; 118 (24): 2596-648
51. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebocontrolled trial. Lancet 2005 Nov 5; 366 (9497): 1622-32
52. Balcetyte-Harris N, Tamis JE, Homel P, et al. Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: results of a pilot study. Ann Noninvasive Electrocardiol 2002 Apr; 7 (2): 86-91 (Pubitemid 34651903)
53. Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011 Mar 15; 123 (10): e269-367
54. Balser JR, Martinez EA, Winters BD, et al. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 1998 Nov; 89 (5): 1052-9 (Pubitemid 28516528)
55. Mooss AN, Wurdeman RL, Mohiuddin SM, et al. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Am Heart J 2000 Jul; 140 (1): 176-80 (Pubitemid 30471260)
56. Payne NA, Prudic J. Electroconvulsive therapy: part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract 2009 Sep; 15 (5): 346-68
57. Weinger MB, Partridge BL, Hauger R, et al. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analg 1991 Nov; 73 (5): 556-62
58. van der Starre PJ, Lemmens HJ, Chandel A, et al. The effects of esmolol and labetalol on cerebral blood flow velocity during electroconvulsive therapy. Eur J Anaesthesiol 2008 Feb; 25 (2): 174-6
59. Zvara DA, Brooker RF, McCall WV, et al. The effect of esmolol on STsegment depression and arrhythmias after electroconvulsive therapy. Convuls Ther 1997 Sep; 13 (3): 165-74 (Pubitemid 27439131)